RxDoctor Payments Data

Farnel Backer, MD

Hospitalist · Greenville, SCNPI 1033302575

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $203, more than ten times the $15 reported in 2019.

$673in general payments, 2019–2025

Across 31 payments — averaging $21.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inari Medical, Inc.$124
  • Pfizer$123
  • Vivus LLC$120
  • Stryker$67
  • Novartis$63
  • E.r. Squibb & Sons, L.L.C.$36
  • plus $140 from 7 others

What the payments were for

  • Food & beverage$673100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$673 in reported general payments places this provider in the 85th percentile of 398 hospitalist providers in South Carolina.

See all hospitalist providers in South Carolina

Medicare billing

Part B allowed, 2024
$160,254
Medicare patients
429
Services billed
1,629

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Breo ElliptaFluticasone/Vilanterol12$4,660
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$1,345
Albuterol Sulfate HfaAlbuterol Sulfate18$503
Pantoprazole Sodium18$180
Gabapentin12$118
Metoprolol Succinate11$64
Losartan Potassium15$62
Amlodipine Besylate16$56
Levofloxacin20$53
Prednisone26$47
Levothyroxine Sodium11$45
Oxycodone Hcl15$44
Carvedilol11$39
Furosemide17$26
Metoprolol Tartrate11$26

Paid to pharmacies, not to this prescriber.

Other hospitalist in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →